Transduction of the IL-21 and IL-23 genes in human pancreatic carcinoma cells produces natural killer cell-dependent and -independent antitumor effects

This publication has 20 references indexed in Scilit:

• Expression of the interleukin-21 gene in murine colon carcinoma cells generates systemic immunity in the inoculated hosts
  Cancer Gene Therapy, 2003
• A Receptor for the Heterodimeric Cytokine IL-23 Is Composed of IL-12Rβ1 and a Novel Cytokine Receptor Subunit, IL-23R
  The Journal of Immunology, 2002
• IL-21 Limits NK Cell Responses and Promotes Antigen-Specific T Cell Activation
  Immunity, 2002
• Cutting Edge: The Common γ-Chain Is an Indispensable Subunit of the IL-21 Receptor Complex
  The Journal of Immunology, 2001
• Cytokines: IL-21 joins the γc-dependent network?
  Current Biology, 2001
• Impaired tumorigenicity of human pancreatic cancer cells retrovirally transduced with interleukin-12 or interleukin-15 gene
  Cancer Gene Therapy, 2000
• Requirement for V _α 14 NKT Cells in IL-12-Mediated Rejection of Tumors
  Science, 1997
• Functional diversity of helper T lymphocytes
  Nature, 1996
• Local production of the p40 subunit of interleukin 12 suppresses T-helper 1-mediated immune responses and prevents allogeneic myoblast rejection.
  Proceedings of the National Academy of Sciences, 1996
• Mouse interleukin‐12 (IL‐12) p40 homodimer: a potent IL‐12 antagonist
  European Journal of Immunology, 1995